By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AcelRx Pharmaceuticals 

575 Chesapeake Drive

Redwood City  California  94063  U.S.A.
Phone: 650-216-3500 Fax: 650-216-6500




Company News
AcelRx Pharmaceuticals (ACRX) Provides Regulatory Update On Zalviso™ 9/26/2014 9:52:07 AM
AcelRx Pharmaceuticals (ACRX) Announces Publication Of Manuscript Analyzing Cost Of Intravenous Patient-Controlled Analgesia With Opioids 9/10/2014 8:37:50 AM
AcelRx Pharmaceuticals (ACRX) Announces Publication Of Sufentanil Sublingual Tablet System Vs. Intravenous Patient-Controlled Analgesia With Morphine For Postoperative Pain Study Results 9/5/2014 10:39:39 AM
AcelRx Pharmaceuticals (ACRX) To Participate In Two Upcoming Investor Events 8/27/2014 8:22:40 AM
AcelRx Pharmaceuticals (ACRX) Reports Second Quarter 2014 Financial Results 8/12/2014 8:36:47 AM
AcelRx Pharmaceuticals (ACRX) To Participate In Three Upcoming Investor Events 8/8/2014 8:39:27 AM
AcelRx Pharmaceuticals (ACRX) To Hold Second Quarter Financial Results Conference Call And Webcast On Monday, August 11th, 2014 8/7/2014 9:36:27 AM
FDA Rejects Redwood City's AcelRx Pharmaceuticals (ACRX) Painkiller Dispensing Device; Stock Plunges -34.35% At 9:37AM ET 7/28/2014 6:17:43 AM
AcelRx Pharmaceuticals (ACRX) Confirms July 27, 2014 PDUFA Date For Zalviso 7/25/2014 9:08:46 AM
AcelRx Pharmaceuticals (ACRX) And Grunenthal Announce Submission Of European Marketing Authorization Application For ZALVISO™ 7/7/2014 8:47:41 AM